New study finds that PROMETAT, a controversial methamphetamine treatment program, is ineffective
Tuesday, November 15, 2011 - 04:00
in Health & Medicine
A recent study has found that PROMETAT, a popular but controversial treatment for methamphetamine addiction, is no more effective than placebo in reducing methamphetamine use, keeping users in treatment, or reducing cravings for methamphetamine. The study was funded by Hythiam, the company that owns the PROMETAT protocol, and is published online today in the scientific journal Addiction.